People: Ascendis Pharma A/S (ASND.OQ)

ASND.OQ on NASDAQ Stock Exchange Global Select Market

1:30am IST
Change (% chg)

$6.33 (+5.65%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Sprogoee, Kennett 

Dr. Kennett Sprogoee, Ph.D., is the Senior Vice President - Product Innovation and Research of Ascendis Pharma A/S since January 2016. He has held positions of increasing responsibility at Ascendis Pharma since December 2007 and as Vice President, Product Innovation from June 2014 to January 2016 and Director, Portfolio Development from November 2012 to June 2014. Prior to joining Ascendis Pharma, Dr. Sprogoee conducted research at the University of Copenhagen, where he applied novel hyphenated screening technologies to expedite discovery of drug leads from natural sources. Dr. Sprogoee holds a Ph.D. in Natural Products Chemistry from the University of Copenhagen and a M.Sc. in Pharmacy from the Danish University of Pharmaceutical Sciences.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --